Craft

Becton, Dickinson and Company

Stock Price

$237.5

2024-10-29

Market Capitalization

$68.7 B

2024-10-29

Revenue

$21.8 B

FY, 2025

Becton, Dickinson and Company Summary

Company Summary

Overview
Becton, Dickinson and Company (BD) is a company that develops, manufactures, and sells medical supplies, laboratory equipment, and diagnostic products. It offers connectors and extension sets, hypodermic syringes, anesthesia needles and trays, disposal systems, fluorescence-activated cell sorters and analyzers, etc. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, pharma, and other industries.
Type
Public
Status
Active
Founded
1897
HQ
Franklin Lakes, NJ, US | view all locations
Website
https://www.bd.com/en-us
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Tom Polen

    Tom Polen, Chairman, Chief Executive Officer, and President

  • Christopher DelOrefice

    Christopher DelOrefice, Executive Vice President and Chief Financial Officer

  • Ronald Silverman

    Ronald Silverman, Executive Vice President and Chief Medical Officer

  • Elizabeth McCombs

    Elizabeth McCombs, Executive Vice President and Chief Technology Officer

Operating MetricsView all

Facility Space Leased, sq. ft.

8M

FY, 2024

Business Segments

3

FY, 2024

Facility Space Owned, sq. ft.

18.5M
2.3%

FY, 2024

LocationsView all

88 locations detected

  • Franklin Lakes, NJ HQ

    United States

    1 Becton Drive

  • Andover, MA

    United States

    200 Bulfinch Dr

  • Broken Bow, NE

    United States

    150 S 1st Ave

  • Canaan, CT

    United States

    7 Grace Way

  • Cockeysville, MD

    United States

    250 Schilling Cir, Hunt Valley

  • Columbus, NE

    United States

    920 19th St E

and 82 others

Becton, Dickinson and Company Financials

Summary Financials

Revenue (Q2, 2026)
$4.7B
Gross profit (Q2, 2026)
$2.2B
Net income (Q2, 2026)
($311.0M)
Cash (Q2, 2026)
$813.0M
EBIT (Q2, 2026)
$93.0M
Enterprise value
$85.1B

Footer menu